Business Standard
Saturday, May 26, 2012
drived banner
drived banner
  Advanced Search
RSS
Content Guide
Follow us on  
||||||Life & Leisure||| 
 Section Home | People | Features | Enterprise | Columnists | Gadgets & Gizmos | Travel | How to Spend It | Book Review | Leisure & Sports
Home > Life & Leisure
 

Savvy marketing sees surge in alternative therapies
Press Trust of India / New Delhi Jun 30, 2009, 13:32 IST

With the rise in the health problems under the category of lifestyle diseases, the alternate systems of medicines like ayurveda, homeopathy have witnessed impressive growth over the years with time-tested methodologies and marketing techniques.  

India's expertise in traditional treatments such as homeopathy, naturopathy, ayurveda and unani are becoming increasingly popular as these have no side effects, according to industry chambers.  

"The demand for Ayurvedic medicines has increased in the last five years to more than Rs 3,000 crore, as they have started marketing their products in a better manner and also conducted scientific trials to prove the permanent cure of some diseases" says Anoop Misra, Department of Diabetes and Metabolism, Fortis Group of Hospitals.  

However, he adds, there is no alternative to allopathy as far as the emergency and cardiac medicines are concerned.  

According to the World Health Organisation, more than one billion people use herbal medicines and in India more than 65 per cent people living in the rural areas use Ayurveda and medical plants to meet their primary health care needs.  

India has over 7.5 million qualified doctors, who, according to Assocham, charge 'reasonable professional fees'. There are over 400,000 registered homoeopaths in the country currently, with approximately 13,000 more being added every year.

Amrit Kalsi, Senior Medical Officer, Delhi Government, says, "The demand for homeopathic and ayurvedic medicines has increased in the last few years and to cure chronic ailments such as respiratory diseases, fevers, skin diseases, viral infections, asthma and allergic disorders, people are choosing the traditional way of treatment before allopathic."  

There were 28 homoeopathic dispensaries in Delhi in 1978 and the number now has gone up to 78. The number of patients taking homeopathic medicines has increased from around 800,000 patients in 1997 to 13,62,174 patients in 2006, she adds.  

"Ayurveda is certainly gaining ground. People suffering from acute or chronic ailments, either go for strong pills or ayurveda. For a disease like cancer, after some of point of time, people lose hope and then go for options like ayurveda or homeopathy," Misra says.  

An industry report say that by 2010, domestic homeopathy market is expected to more than double and touch the Rs 26 billion (Rs 2600 crore) size. It would continue to grow at between 25-30 per cent against 13-15 per cent of pharmaceuticals industry as users of homeopathy are multiplying not only in India but also throughout the world.  

"The demand for Ayurvedic medicine has also gradually improved for the rising number of lifestyle diseases like stress, migraine, asthma, obesity. But in cases like surgeries or emergency operations, there is no alternative," says Misra.

"Government spends only three per cent of the total health budget on all alternative system of medical therapies including Ayurveda. Even if half of the share spent on mainstream treatment, is being given to Ayurveda, then with research and scientific trials it can complement allopathic treatment in equal manner", says social activist Swami Agnivesh.  

Private hospitals have become very expensive and with the news of duplicate medicines and their side effects, Ayurveda is a safer option, he adds.  

The health ministry recently has decided to develop agricultural clusters for cultivation of medicinal herbs and expected to increase the export potential in herbal medicine sector up to Rs 1,000 crore annually.  

However, some reports suggest that the global economic meltdown has also affected the ayurveda spa business and taken its toll on tourist arrivals across Kerala and the sector is foreseeing at least a 30-40 per cent dip in income this monsoon season.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Markets end flat
- SAIL to add 5 mn tonne capacity in FY13
- NHPC FY12 net up 28% at Rs 2,772 cr
- Aarti Industries Q4 up nearly 27% at Rs 28.24 crore
- BPCL posts four-fold jump in Q4 net at Rs 3,963 cr
  Read Business news in 
- Journey on, We are by Your Side. Click here to know more
- Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol.
- The Best Seller is Also the No. 1 in Mileage. Click here
- Watch The Film Here. Click here to know more..
- Leader in Passenger Car & Automobile Tyres. Click here
- 1 billion in saving for Unilever without any tangles.
- Learn How One City is Running on FOOD SCRAPS.
- One Partnership Endless Possibilities. Click here to know more
- Helping doctors detect diseases earlier, saving costs & extending lives.
- 36 Lakhs can get you a pool of Luxuries. Click here
- Which is the best plan for your daughter
- Check out the TRUE COLOURS of your Stocks, Now for FREE!
- One of the leading business schools in the world.Know More
Sorry, comments to this story are closed
Latest Messages
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
BS POLL
UPA 2 has completed three years. How do you rate its performance?  Read the story
  Good
  Average
  Bad
Submit
Most Popular
Read
E-Mailed
Commented
   
- Reddy rules out rollback of rise in petrol prices
- Ajit Singh meets striking pilots
- IPL on turning track, broadcast revenue down by a third
- FIIs bet heavily in Indian market, but in Singapore
- No country for easy skill development
 
 More  
New Ipad Application
 Business Standard's all new IPad  App
 Click here to download for free
  Hot Searches  
 
Apalya |  Air India |  GAAR |  Agni  |  Solar eclipse |  Satyamev Jayate |  SRK |  Aamir Khan |  IPL |  Ertiga |  Sarfaesi Act |  Vodafone |  JP Morgan |  Transfer pricing |  Rupee |  Kingfisher Airlines |  Silver |  Provident Fund |  income tax refund |  iPhone |  Reliance Industries |  SEBI |  BSNL |  BSE |  NSE |  Mukesh Ambani |  Anil Ambani |  Infosys |  Pranab Mukherjee |  Sonia Gandhi |  Rahul Gandhi |  New Pension Scheme |  Reliance |  RBI |  GDP |  Gold |  Ratan Tata |  ICICI |  B-School |  Sensex |  Tax calculator |  Home Loan |  Personal Finance |  inflation |  oil prices |  Barack Obama |   
 
  Member Area Write to the Editor RSS Archives Advanced Search
  Subscribe to BS print product BS e-paper Newsletter Portfolio Tracker
  BS Products BS Hindi BS Motoring BS Books
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us